Quarterly report · Q2
9627.TEDINET S100SH2U
Period2023-05-01 → 2023-10-31
Filed2023-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥193.7bn | 2023-05-01 → 2023-10-31 | Cons. | Net sales |
| Revenue | ¥358.7bn | 2022-05-01 → 2023-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥171.2bn | 2022-05-01 → 2022-10-31 | Cons. | Net sales |
| Operating income | ¥8.7bn | 2023-05-01 → 2023-10-31 | Cons. | Operating income |
| Operating income | ¥6.8bn | 2022-05-01 → 2022-10-31 | Cons. | Operating income |
| Ordinary income | ¥9.3bn | 2023-05-01 → 2023-10-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.1bn | 2022-05-01 → 2023-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.3bn | 2022-05-01 → 2022-10-31 | Cons. | Ordinary income |
| Profit before tax | ¥9.4bn | 2023-05-01 → 2023-10-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.2bn | 2022-05-01 → 2022-10-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.3bn | 2023-05-01 → 2023-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2022-05-01 → 2023-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.8bn | 2022-05-01 → 2022-10-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥5.2bn | 2023-05-01 → 2023-10-31 | Cons. | Profit loss |
| Net income | ¥3.8bn | 2022-05-01 → 2022-10-31 | Cons. | Profit loss |
| Total assets | ¥242.9bn | at 2023-10-31 | Cons. | Assets |
| Total assets | ¥231.8bn | at 2023-04-30 | Cons. | Assets |
| Total assets | ¥231.3bn | at 2022-10-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥113.1bn | at 2023-10-31 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2023-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥129.8bn | at 2023-10-31 | Cons. | Net assets |
| Net assets / equity | ¥126.5bn | at 2023-04-30 | Cons. | Net assets |
| Net assets / equity | ¥120.9bn | at 2022-10-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.5bn | at 2023-10-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥46.8bn | at 2023-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥50.3bn | at 2023-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.2bn | at 2023-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥43.5bn | at 2022-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥59.5bn | at 2022-04-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥14.1bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.3bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.5bn | 2022-05-01 → 2022-10-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥5.8bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥22.3bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥18.6bn | 2022-05-01 → 2022-10-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.2bn | 2023-05-01 → 2023-10-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.2bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.8bn | 2022-05-01 → 2022-10-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥149.66 | 2023-05-01 → 2023-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.73 | 2023-08-01 → 2023-10-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.87 | 2022-05-01 → 2023-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.32 | 2022-05-01 → 2022-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.78 | 2022-08-01 → 2022-10-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 53.4% | at 2023-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.2% | at 2022-10-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-05-01 → 2023-10-31 | ¥5.7bn |
| Otherother segments | revenue external | 2023-05-01 → 2023-10-31 | ¥5.7bn |
| Otherother segments | revenue intersegment | 2023-05-01 → 2023-10-31 | ¥24m |
| Otherother segments | segment ordinary income | 2023-05-01 → 2023-10-31 | −¥49m |
| Reconciling Itemsreconciling | revenue | 2023-05-01 → 2023-10-31 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-05-01 → 2023-10-31 | −¥24m |
| Reconciling Itemsreconciling | segment ordinary income | 2023-05-01 → 2023-10-31 | −¥4.4bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2023-05-01 → 2023-10-31 | ¥173.2bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2023-05-01 → 2023-10-31 | ¥173.2bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2023-05-01 → 2023-10-31 | ¥12.5bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2023-05-01 → 2023-10-31 | ¥14.8bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2023-05-01 → 2023-10-31 | ¥14.8bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2023-05-01 → 2023-10-31 | ¥1.3bn |
| —segment total | revenue | 2023-05-01 → 2023-10-31 | ¥193.8bn |
| —segment total | revenue external | 2023-05-01 → 2023-10-31 | ¥193.7bn |
| —segment total | revenue intersegment | 2023-05-01 → 2023-10-31 | ¥24m |
| —segment total | segment ordinary income | 2023-05-01 → 2023-10-31 | ¥13.8bn |
| Otherother segments | revenue | 2022-05-01 → 2022-10-31 | ¥5.8bn |
| Otherother segments | revenue external | 2022-05-01 → 2022-10-31 | ¥5.8bn |
| Otherother segments | revenue intersegment | 2022-05-01 → 2022-10-31 | ¥31m |
| Otherother segments | segment ordinary income | 2022-05-01 → 2022-10-31 | −¥18m |
| Reconciling Itemsreconciling | revenue | 2022-05-01 → 2022-10-31 | −¥31m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-05-01 → 2022-10-31 | −¥31m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-05-01 → 2022-10-31 | −¥3.8bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2022-05-01 → 2022-10-31 | ¥153.2bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2022-05-01 → 2022-10-31 | ¥153.2bn |
| jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2022-05-01 → 2022-10-31 | ¥10.8bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2022-05-01 → 2022-10-31 | ¥12.2bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2022-05-01 → 2022-10-31 | ¥12.2bn |
| jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2022-05-01 → 2022-10-31 | ¥349m |
| —segment total | revenue | 2022-05-01 → 2022-10-31 | ¥171.2bn |
| —segment total | revenue external | 2022-05-01 → 2022-10-31 | ¥171.2bn |
| —segment total | revenue intersegment | 2022-05-01 → 2022-10-31 | ¥31m |
| —segment total | segment ordinary income | 2022-05-01 → 2022-10-31 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 555
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 3889000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1107 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 3239000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0922 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 2750000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0783 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1743000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0496 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1594000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0454 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 1472000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0419 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 1281000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0365 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 1185000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0338 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 1108000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0316 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 717000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0204 | |
| Number of shares held | CurrentQuarterInstant | 18983000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.5403 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 295700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 35111700 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 351117 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 20812 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 35428212 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 351117 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 295700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 295700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0083 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 295700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 295700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0083 | |
| Cash and deposits | Prior1YearInstant | 46796000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 50518000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 13249000000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 13643000000 | JPY |
| Merchandise | Prior1YearInstant | 21299000000 | JPY |
| Merchandise | CurrentQuarterInstant | 24567000000 | JPY |
| Supplies | Prior1YearInstant | 286000000 | JPY |
| Supplies | CurrentQuarterInstant | 288000000 | JPY |
| Short term loans receivable | Prior1YearInstant | 355000000 | JPY |
| Short term loans receivable | CurrentQuarterInstant | 233000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |